The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

Belviq for Weight Loss Is Now Available!

by Elizabeth Davis on June 11, 2013 at 8:24 am

Belviq is finally available in pharmacies, nearly a year after its FDA approval in June 2012.

DEA approval was required before the launch because of some of the side effects at higher doses, causing the delay in availability. Belviq is now being released as a Schedule IV drug, the second least restrictive DEA classification. This means it is considered to have a low potential for abuse compared to higher schedules and has an accepted medical use. Ambien, Provigil, and phentermine (Adipex-P) are other examples of Schedule IV drugs.

There are some reasons to be excited about Belviq: the average weight loss on Belviq over a year is 3% – 3.7%, up to about 5%. It’s also important to be aware of the potential side effects though, including slowed thinking, sleepiness, confusion, and hallucinations and euphoria at higher doses.

See Dr. O’s thoughts on Belviq here and check out the current prices and coupons available in your area.

Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.